Safety and efficacy of transurethral Thulium laser resection of high-risk stage bladder tumor in anticoagulant state

Abstract

Objective To study safety and efficacy of transurethral Thulium laser resection of high-risk stage bladder tumor in anticoagulant state. Methods A total of 26 non-muscle invasive bladder cancer patients receiving long-term anticoagulant therapy, including 16 cases with cerebral infarction, 7 cases with coronary heart disease, 3 patients with coronary stenting, were retrospectively analyzed in our hospital from July 2012 to July 2014.In condition not stopping anticoagulants, Thulium laser transurethral resection of bladder tumor was performed, and hemoglobin, thrombin time, the operative time, intraoperative blood loss, postoperative bladder irrigation duration, postoperative hospital stay, bladder tumor recurrence within two years, the postoperative complications were recorded before and after surgery. Results All patients were successfully treated.The operative time was(29.1±12.8)min, intraoperative blood loss was(29.4±16.9) ml portions, postoperative bladder irrigation time was(1.25±0.55)d, postoperative hospital stay was(5.51±1.06)d.Hemoglobin before and after operation were(131.35±6.57)g/L and(129.75±11.05)g/L respectively, there was no statistically significant differences(t=1.014, P>0.05)between them.Prothrombin time before and after operation were(12.50±0.25)s and(12.44±0.27)s, with no statistically significant difference(t=0.908, P>0.05)between them.During the followed-up of 48 months, tumor recurred at heterotopia in 2 patients. Conclusions Thulium laser transurethral resection of bladder tumor is safe and effective for patients undergoing long-term oral anticoagulation drugs, without a need to stop taking anticoagulant drugs. Key words: Lasers; Urinary bladder neoplasms